XML 183 R143.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments - Changes in Numbers of Outstanding Awards Under Our Cash-Settled Plans (Details)
item in Thousands
12 Months Ended
Dec. 31, 2017
EUR (€)
item
Dec. 31, 2016
EUR (€)
item
Dec. 31, 2015
EUR (€)
item
SHARE-BASED PAYMENTS      
Total carrying amount of liabilities | € € 1,154,000,000 € 911,000,000  
Total expense recognized | € € 963,000,000 € 678,000,000 € 637,000,000
LTI 2016 Plan      
SHARE-BASED PAYMENTS      
Beginning of period 377 0  
Granted 295 389  
Exercised 0 0  
Forfeited (41) (12)  
End of period 631 377 0
Exercisable 0 0  
Total carrying amount of liabilities | € € 22,000,000 € 7,000,000  
Total intrinsic value of vested awards | € 5,000,000 2,000,000  
Total expense recognized | € € 14,000,000 € 7,000,000 € 0
LTI 2015 Plan      
SHARE-BASED PAYMENTS      
Beginning of period 684 977  
Granted 0 0  
Adjustment based upon KPI target achievement 0 0  
Exercised (152) (294)  
Forfeited 0 0  
End of period 531 684 977
Exercisable 0 0  
Total carrying amount of liabilities | € € 51,000,000 € 58,000,000  
Total intrinsic value of vested awards | € 49,000,000 58,000,000  
Weighted averge share price for share options exercised in (in Euro per share) | € 84.94 72.55  
Total expense recognized | € € 9,000,000 € 7,000,000 € 28,000,000
SOP      
SHARE-BASED PAYMENTS      
Beginning of period 23,375 29,127  
Granted 0 0  
Exercised (7,769) (4,693)  
Forfeited (1,134) (1,059)  
End of period 14,472 23,375 29,127
Exercisable 4,948 5,472  
Total carrying amount of liabilities | € € 354,000,000 € 385,000,000  
Total intrinsic value of vested awards | € 172,000,000 154,000,000  
Weighted averge share price for share options exercised in (in Euro per share) | € 91.13 78.74  
Total expense recognized | € € 221,000,000 € 183,000,000 € 187,000,000
RSU      
SHARE-BASED PAYMENTS      
Beginning of period 10,901 5,577  
Granted 7,835 9,104  
Adjustment based upon KPI target achievement (124) (66)  
Exercised (4,388) (2,659)  
Forfeited (704) (1,055)  
End of period 13,520 10,901 5,577
Exercisable 0 0  
Total carrying amount of liabilities | € € 708,000,000 € 436,000,000  
Total intrinsic value of vested awards | € 0 0  
Weighted averge share price for share options exercised in (in Euro per share) | € 90.91 74.74  
Total expense recognized | € € 712,000,000 € 458,000,000 € 193,000,000